Seeks to further amend notification No. 16/2017-Customs dated 20th April, 2017, which provides exemption to specified medicines under certain Patient Assistance Programmes (PAPs) run by pharmaceutical companies. Notification No. 41/2020-Customs dated 29th October, 2020

GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(DEPARTMENT OF REVENUE)

Notification No. 41/2020-Customs

New Delhi, the 29th October, 2020

G.S.R. …(E). – In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act,1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do, hereby makes the following further amendments in the notification of the Government of India, in the Ministry of Finance (Department of Revenue), No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R.394 (E), dated the 20th April, 2017, namely:-

In the said notification, in the Table, for the entries in column (3) and column (4) at the serial numbers given in column (1) of the Table below, the corresponding entries at column (2) and column (3) of the Table below shall be substituted, namely:-

Table

(1) (2) (3)
17. “Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited
1. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited
2. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited
3. Win for Patients- Cancer Care/ Umaang Sandoz India Private Limited
4. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited
5. Win for Patients- Cancer Care/ Umaang Novartis Healthcare Private Limited
43. Sutent Patient Assistance Programme – STAR Pfizer Products India Private Limited
6. Crizalk Patient Assistance Programme – STAR Pfizer Products India Private Limited
7. Inlyta Patient Assistance Programme – STAR Pfizer Products India Private Limited
8. Palbace Patient Assistance Programme – PRERNA Pfizer Products India Private Limited
9. Enbrel Patient Assistance Programme Pfizer Limited
10. Xeljanz Patient Assistance Programme Pfizer Limited
11. Genotropin Patient Assistance Programme Pfizer Products India Private Limited
12. Atgam Patient Assistance Programme Pfizer Products India Private Limited
13. Aromasin Patient Assistance Programme Pfizer Products India Private Limited
14. Campto Patient Assistance Programme Pfizer Products India Private
Limited”.

[F. No. 332/24/2010-TRU (Pt.III)]

(Gaurav Singh)
Deputy Secretary to the Government of India

Note: The principal notification No. 16/2017-Customs, dated the 20th April, 2017 was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R.394 (E), dated the 20th April, 2017, and was last amended by notification No. 83/2017-Customs, dated the 31st October, 2017 published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R. 1356 (E), dated the 31st October, 2017.

More Under Custom Duty

Leave a Comment

Your email address will not be published. Required fields are marked *

Search Posts by Date

November 2020
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30